Current Cancer Drug Targets


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204


Become EABM
Become Reviewer

Volume 19 - Issue 3

Meet Our Editorial Board Member promotion: free to download

Volume: 19   Issue: 3
Pp: 161-161
M.P. Carty
DOI: 10.2174/156800961903190214151927

Focal Adhesion Kinase in Ovarian Cancer: A Potential Therapeutic Target for Platinum and Taxane-Resistant Tumors

Volume: 19   Issue: 3
Pp: 179-188
Arkene Levy*, Khalid Alhazzani, Priya Dondapati, Ali Alaseem, Khadijah Cheema, Keerthi Thallapureddy, Paramjot Kaur, Saad Alobid and Appu Rathinavelu
DOI: 10.2174/1568009618666180706165222

Efficacy and Safety of Antigen-specific Immunotherapy in the Treatment of Patients with Non-small-cell Lung Cancer: A Systematic Review and Meta-analysis

Volume: 19   Issue: 3
Pp: 199-209
Bing-Di Yan, Xiao-Feng Cong, Sha-Sha Zhao, Meng Ren, Zi-Ling Liu, Zhi Li, Chen Chen and Lei Yang*
DOI: 10.2174/1568009618666180430124738

The Biological Activity of the Novel Vinca Alkaloids 4-chlorochablastine and 4-chlorochacristine

Volume: 19   Issue: 3
Pp: 222-230
Gracia Montag, Helga Stopper, Quoc Anh Ngo and Henning Hintzsche*
DOI: 10.2174/1568009618666180430142233

Cathepsin L Induces Proangiogenic Changes in Human Omental Microvascular Endothelial Cells via Activation of the ERK1/2 Pathway

Volume: 19   Issue: 3
Pp: 231-242
Md Zahidul I. Pranjol, Nicholas J. Gutowski, Michael Hannemann and Jacqueline L. Whatmore*
DOI: 10.2174/1568009618666180831123951